STING1 and metabolic dysfunction-associated steatohepatitis: Increased expression of STING is detected in the liver of NAFL (Luo et al., 2018) and NASH (Wang et al., 2020b) human patients compared with the respective control, especially in the liver portal tract of NASH patients with fibrosis compared to that of healthy controls.